Edap TMS SA (EDAP)
6.84
-0.25
(-3.53%)
USD |
NASDAQ |
Apr 24, 16:00
6.87
+0.03
(+0.44%)
After-Hours: 20:00
Edap TMS Total Assets (Quarterly): 101.20M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 101.20M |
September 30, 2023 | 98.72M |
June 30, 2023 | 103.60M |
March 31, 2023 | 109.88M |
December 31, 2022 | 108.44M |
September 30, 2022 | 103.01M |
June 30, 2022 | 84.92M |
March 31, 2022 | 85.33M |
December 31, 2021 | 87.44M |
September 30, 2021 | 85.47M |
June 30, 2021 | 88.80M |
March 31, 2021 | 62.48M |
December 31, 2020 | 67.89M |
September 30, 2020 | 60.63M |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 59.45M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 55.75M |
September 30, 2018 | |
June 30, 2018 | 53.97M |
March 31, 2018 | |
December 31, 2017 | 56.26M |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | 52.26M |
March 31, 2017 | |
December 31, 2016 | 49.25M |
September 30, 2016 | |
June 30, 2016 | 51.94M |
March 31, 2016 | |
December 31, 2015 | 42.18M |
September 30, 2015 | |
June 30, 2015 | 38.02M |
March 31, 2015 | |
December 31, 2014 | 39.10M |
September 30, 2014 | |
June 30, 2014 | 44.45M |
March 31, 2014 | |
December 31, 2013 | 37.11M |
September 30, 2013 | |
June 30, 2013 | 35.11M |
March 31, 2013 | |
December 31, 2012 | 40.26M |
September 30, 2012 | 32.06M |
June 30, 2012 | 38.41M |
March 31, 2012 | |
December 31, 2011 | 41.76M |
September 30, 2011 | 35.20M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
59.45M
Minimum
Dec 2019
109.88M
Maximum
Mar 2023
87.15M
Average
87.44M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
DBV Technologies SA | 182.99M |
Biophytis SA | 13.22M |
Cellectis SA | 209.70M |
Adaptimmune Therapeutics PLC | 282.62M |
NuCana PLC | 35.43M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 38.27M |
Shareholders Equity (Quarterly) | 62.92M |
Debt to Equity Ratio | 0.1057 |
Current Ratio | 2.844 |
Net Debt Paydown Yield | -0.15% |